Kintegral Advisory LLC reduced its position in The Clorox Company (NYSE:CLX – Free Report) by 4.5% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 15,114 shares of the company’s stock after selling 704 shares during the period. Kintegral Advisory LLC’s holdings in Clorox were worth $2,455,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently modified their holdings of the business. Insight Folios Inc grew its stake in shares of Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after purchasing an additional 63 shares during the last quarter. HCR Wealth Advisors raised its holdings in Clorox by 1.0% in the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after purchasing an additional 68 shares in the last quarter. Empower Advisory Group LLC lifted its position in shares of Clorox by 4.5% in the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after purchasing an additional 78 shares during the period. Aviance Capital Partners LLC boosted its stake in shares of Clorox by 2.7% during the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after purchasing an additional 80 shares in the last quarter. Finally, Lindbrook Capital LLC increased its position in shares of Clorox by 9.9% during the third quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock valued at $159,000 after buying an additional 88 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on the stock. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their price objective for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Barclays raised their target price on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. Wells Fargo & Company upped their price target on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $158.21.
Clorox Stock Up 2.8 %
Shares of Clorox stock opened at $157.41 on Friday. The company has a 50-day simple moving average of $157.87 and a two-hundred day simple moving average of $159.63. The stock has a market capitalization of $19.39 billion, a PE ratio of 43.01, a price-to-earnings-growth ratio of 2.58 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the company posted $2.16 earnings per share. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- About the Markup Calculator
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Airline Stocks – Top Airline Stocks to Buy Now
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Trading Halts Explained
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.